Previous studies showed that DPP-4 activities in serum of OSCC patients when registered at different intervals of treatment revealed a dynamic change in its activities reflecting the clinical status of patients where DPP-4 values were elevated with tumor regression and reduced with cancer progression. Here, DPP4 is linked to cancer.